These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 20194044)
1. Treatment of toxoplasmic lymphadenitis with co-trimoxazole: double-blind, randomized clinical trial. Alavi SM; Alavi L Int J Infect Dis; 2010 Sep; 14 Suppl 3():e67-9. PubMed ID: 20194044 [TBL] [Abstract][Full Text] [Related]
2. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866 [TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion. Holland GN Ophthalmology; 2005 Nov; 112(11):1882-4. PubMed ID: 16271316 [No Abstract] [Full Text] [Related]
4. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. Stegeman CA; Tervaert JW; de Jong PE; Kallenberg CG N Engl J Med; 1996 Jul; 335(1):16-20. PubMed ID: 8637536 [TBL] [Abstract][Full Text] [Related]
5. New perspectives in the chemotherapy of toxoplasmosis. Terragna A; Canessa A J Chemother; 1989 Jul; 1(4 Suppl):935-7. PubMed ID: 16312712 [No Abstract] [Full Text] [Related]
14. Double-blind co-operative trial to compare trimethoprim-sulfalene and co-trimoxazole in the treatment of lower respiratory tract infections. Ferlinz R; Lorenz J; Micka K; Noseda PG; Pfister B; Trendelenburg F Arzneimittelforschung; 1983; 33(11):1609-12. PubMed ID: 6362676 [TBL] [Abstract][Full Text] [Related]
15. Current therapy for isolated toxoplasmic lymphadenopathy. Anton E Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Apr; 107(4):450; author reply 450. PubMed ID: 19327634 [No Abstract] [Full Text] [Related]
16. Toxoplasmosis after hematopoietic stem cell transplantation. Martino R; Maertens J; Bretagne S; Rovira M; Deconinck E; Ullmann AJ; Held T; Cordonnier C Clin Infect Dis; 2000 Nov; 31(5):1188-95. PubMed ID: 11073751 [TBL] [Abstract][Full Text] [Related]
17. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study. Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic protocols for lymphoglandular toxoplasmosis. Carosi G; Ghezzi L; Minoli L; Parisi A; Maccabruni A Int J Biol Res Pregnancy; 1981; 2(3):128-33. PubMed ID: 7037654 [TBL] [Abstract][Full Text] [Related]
19. Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006. Béraud G; Pierre-François S; Foltzer A; Abel S; Liautaud B; Smadja D; Cabié A Am J Trop Med Hyg; 2009 Apr; 80(4):583-7. PubMed ID: 19346380 [TBL] [Abstract][Full Text] [Related]
20. Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study. Thamprajamchit S; Chetchotisakd P; Thinkhamrop B J Med Assoc Thai; 1998 Apr; 81(4):265-71. PubMed ID: 9623020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]